MX2009007693A - Composicion de peptido y metodo para promover la formacion de cartilago. - Google Patents
Composicion de peptido y metodo para promover la formacion de cartilago.Info
- Publication number
- MX2009007693A MX2009007693A MX2009007693A MX2009007693A MX2009007693A MX 2009007693 A MX2009007693 A MX 2009007693A MX 2009007693 A MX2009007693 A MX 2009007693A MX 2009007693 A MX2009007693 A MX 2009007693A MX 2009007693 A MX2009007693 A MX 2009007693A
- Authority
- MX
- Mexico
- Prior art keywords
- peptide composition
- cartilage formation
- cartilage
- promoting cartilage
- bone
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 230000022159 cartilage development Effects 0.000 title 1
- 230000001737 promoting effect Effects 0.000 title 1
- 210000000988 bone and bone Anatomy 0.000 abstract 4
- 210000000845 cartilage Anatomy 0.000 abstract 4
- 230000007547 defect Effects 0.000 abstract 3
- 210000001519 tissue Anatomy 0.000 abstract 2
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000008482 osteoarthritis Diseases 0.000 abstract 1
- 230000008929 regeneration Effects 0.000 abstract 1
- 238000011069 regeneration method Methods 0.000 abstract 1
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Materials For Medical Uses (AREA)
Abstract
La presente invención es un compuesto de péptido que estimula la formación de tejidos duros, tal como hueso y cartílago. La presente invención también se relaciona con un método para tratar un defecto en tejidos duros tales como hueso y cartílago utilizando el péptido. El método de la presente invención puede utilizarse para tratar o prevenir los defectos en huesos y cartílagos que son originados por artritis reumatoide u osteoartritis, que implica la regeneración de nuevos huesos o cartílagos en o alrededor de los defectos.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US88596107P | 2007-01-22 | 2007-01-22 | |
| US94005707P | 2007-05-24 | 2007-05-24 | |
| US96905207P | 2007-08-30 | 2007-08-30 | |
| PCT/US2008/000868 WO2008091632A2 (en) | 2007-01-22 | 2008-01-22 | A peptide composition and a method of promoting cartilage formation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2009007693A true MX2009007693A (es) | 2009-08-31 |
Family
ID=39645065
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2009007693A MX2009007693A (es) | 2007-01-22 | 2008-01-22 | Composicion de peptido y metodo para promover la formacion de cartilago. |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US7888462B2 (es) |
| EP (1) | EP2117578B1 (es) |
| JP (1) | JP5579445B2 (es) |
| AU (1) | AU2008209473B2 (es) |
| CA (1) | CA2674384C (es) |
| DK (1) | DK2117578T3 (es) |
| ES (1) | ES2542509T3 (es) |
| MX (1) | MX2009007693A (es) |
| WO (1) | WO2008091632A2 (es) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101029705B1 (ko) * | 2010-06-30 | 2011-04-18 | (주)엔솔테크 | 신규 펩타이드 및 그 용도 |
| US10849958B2 (en) * | 2017-06-14 | 2020-12-01 | Orthotrophix, Inc. | Knee pain evaluation and management via WOMAC and KOOS systems |
| US11963996B2 (en) | 2018-10-24 | 2024-04-23 | Orthotrophix, Inc. | Method of treating knee pain |
| WO2020117360A1 (en) * | 2018-12-04 | 2020-06-11 | Orthotrophix, Inc. | Formulation for use in treating osteoarthritis |
| MX2021003584A (es) * | 2018-12-04 | 2021-10-13 | Orthotrophix Inc | Formulacion para su uso en el tratamiento de la osteoartritis. |
| TWI783314B (zh) * | 2019-12-03 | 2022-11-11 | 中國醫藥大學 | 寡胜肽，其檢測套組，其醫藥組合物與醫藥組合物的用途 |
| CN111346217B (zh) * | 2020-02-27 | 2023-06-27 | 广州领晟医疗科技有限公司 | 多肽tdl23的新用途 |
| CN111569046B (zh) * | 2020-04-14 | 2023-06-27 | 广州领晟医疗科技有限公司 | 多肽在制备治疗胰腺炎药物中的用途及含有其的药物 |
| WO2022072156A1 (en) * | 2020-10-01 | 2022-04-07 | Orthotrophix, Inc. | Hard tissue therapeutics |
| KR102749110B1 (ko) * | 2021-11-04 | 2025-01-03 | (주)케어젠 | 생리 활성을 갖는 펩타이드 및 그의 용도 |
| KR20240086946A (ko) * | 2022-12-09 | 2024-06-19 | (주)케어젠 | 연골 재생용 펩타이드 및 이의 용도 |
| KR20240086947A (ko) * | 2022-12-09 | 2024-06-19 | (주)케어젠 | 연골 재생용 펩타이드 및 이의 용도 |
| KR20240086941A (ko) * | 2022-12-09 | 2024-06-19 | (주)케어젠 | 연골 재생용 펩타이드 및 이의 용도 |
| KR102877150B1 (ko) * | 2022-12-09 | 2025-10-28 | (주)케어젠 | 연골 재생용 펩타이드 및 이의 용도 |
| KR20240086944A (ko) * | 2022-12-09 | 2024-06-19 | (주)케어젠 | 연골 재생용 펩타이드 및 이의 용도 |
Family Cites Families (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5015628A (en) * | 1986-06-12 | 1991-05-14 | The University Of Melbourne | Anticariogenic phosphopeptides |
| DK0536186T3 (da) * | 1990-05-16 | 2002-05-21 | Genetics Inst | Knogle- og brusk-dannelsesfremkaldende proteiner |
| IE66205B1 (en) | 1990-06-14 | 1995-12-13 | Paul A Bartlett | Polypeptide analogs |
| US5853746A (en) * | 1991-01-31 | 1998-12-29 | Robert Francis Shaw | Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone using functional barrier |
| US5804213A (en) | 1991-10-09 | 1998-09-08 | Lectec Corporation | Biologically active aqueous gel wound dressing |
| GB9203958D0 (en) * | 1992-02-25 | 1992-04-08 | Norske Stats Oljeselskap | Catalytic multi-phase reactor |
| EP1258492A1 (en) | 1992-09-24 | 2002-11-20 | Chiron Corporation | N-substituted oligomers and methods for their synthesis, e.g. polyglycine bearing nucleic acid bases |
| US5844013A (en) | 1992-10-02 | 1998-12-01 | Beiersdorf Ag | Hydrophilic polyurethane gel foams, particularly for treating deep wounds, wound dressing based on hydrophilic polyurethane gel foams and method of manufacture |
| US5807306A (en) | 1992-11-09 | 1998-09-15 | Cortrak Medical, Inc. | Polymer matrix drug delivery apparatus |
| US5415629A (en) | 1993-09-15 | 1995-05-16 | Henley; Julian L. | Programmable apparatus for the transdermal delivery of drugs and method |
| US5981478A (en) | 1993-11-24 | 1999-11-09 | La Jolla Cancer Research Foundation | Integrin-binding peptides |
| US6103709A (en) * | 1993-12-23 | 2000-08-15 | The Regents Of The University Of California | Therapeutically effective 1α,25-dihydroxyvitamin D3 analogs and methods for treatment of vitamin D diseases |
| US5770565A (en) * | 1994-04-13 | 1998-06-23 | La Jolla Cancer Research Center | Peptides for reducing or inhibiting bone resorption |
| EP0712635B1 (en) | 1994-05-13 | 2003-05-02 | Kuraray Co., Ltd. | Medical polymer gel |
| GB9415739D0 (en) | 1994-07-30 | 1994-09-21 | Scimat Ltd | Gel wound dressing |
| US6027592A (en) * | 1995-06-06 | 2000-02-22 | Gillette Canada Inc. | Dental floss |
| US6300062B1 (en) * | 1995-07-13 | 2001-10-09 | Biora Ab | Enamel matrix related polypeptide |
| US5700774A (en) * | 1996-03-26 | 1997-12-23 | Genetics Institute, Inc. | Compositions comprising bone morphogenic proteins and truncated parathyroid hormone related peptide, and methods of inducing cartilage by administration of same |
| US5837674A (en) * | 1996-07-03 | 1998-11-17 | Big Bear Bio, Inc. | Phosphopeptides and methods of treating bone diseases |
| US7135459B2 (en) * | 1996-10-16 | 2006-11-14 | Zymogenetics, Inc. | Methods of use of FGF homologs |
| US6509026B1 (en) | 1997-08-15 | 2003-01-21 | Children's Medical Center Corporation | Osteopontin coated surfaces and methods of use |
| US5899876A (en) | 1997-08-27 | 1999-05-04 | Becton, Dickinson And Company | Multiple site drug delivery system |
| US6146655A (en) | 1997-08-29 | 2000-11-14 | Softy-Flex Inc. | Flexible intra-oral bandage and drug delivery system |
| US6410248B1 (en) | 1998-01-30 | 2002-06-25 | Massachusetts Institute Of Technology | General strategy for selecting high-affinity zinc finger proteins for diverse DNA target sites |
| WO1999043844A1 (en) | 1998-02-27 | 1999-09-02 | The Trustees Of Columbia University In The City Of New York | Reciprocal subtraction differential display |
| JP4424575B2 (ja) | 1998-05-18 | 2010-03-03 | ユニバーシティー カレッジ ロンドン | 新規ポリペプチドホルモン・フォスファトニン |
| US6673900B2 (en) * | 1999-11-04 | 2004-01-06 | University College London | Polypeptide hormone-phosphatonin |
| US6045780A (en) * | 1998-06-22 | 2000-04-04 | Shemberg Marketing Corporation | Toothpaste composition |
| ATE250423T1 (de) * | 1998-07-13 | 2003-10-15 | Univ Southern California | Verfahren zur beschleunigen den zuwachs und heilen von knochen und knorpel |
| US6727224B1 (en) * | 1999-02-01 | 2004-04-27 | Genetics Institute, Llc. | Methods and compositions for healing and repair of articular cartilage |
| AUPP893999A0 (en) | 1999-03-01 | 1999-03-25 | Csl Limited | Synthetic peptides containing protective epitopes for the treatment and prevention of periodontitis associated with porphyromonas gingivalis |
| EP1130098A3 (en) * | 2000-02-29 | 2003-09-10 | Pfizer Products Inc. | Mammalian osteoregulins |
| WO2001072826A2 (en) | 2000-03-24 | 2001-10-04 | Genzyme Corporation | Oncogenic osteomalacia-related gene 1 |
| EP1301196B1 (en) | 2000-07-19 | 2003-11-26 | The Board of Regents, The University of Texas System | Stimulation of bone growth with thrombin peptide derivatives |
| AU8326801A (en) | 2000-08-16 | 2002-02-25 | Big Bear Bio Inc | Dental products comprising bone growth enhancing peptide |
| US6911425B2 (en) | 2000-08-16 | 2005-06-28 | Acologix, Inc. | Integrin binding motif containing peptides and methods of treating skeletal diseases |
| EP1503767A2 (en) * | 2002-02-08 | 2005-02-09 | ACOLOGIX, Inc. | Compositions and methods for treatment of vitamin d deficiency |
| JP2006502971A (ja) * | 2002-05-03 | 2006-01-26 | ミレニアム バイオロジックス インコーポレーテッド | 結合組織刺激ペプチド |
| US7638486B2 (en) * | 2005-07-18 | 2009-12-29 | Acologix, Inc. | Method for promoting hard tissue formation |
-
2008
- 2008-01-22 MX MX2009007693A patent/MX2009007693A/es active IP Right Grant
- 2008-01-22 WO PCT/US2008/000868 patent/WO2008091632A2/en not_active Ceased
- 2008-01-22 EP EP20080724721 patent/EP2117578B1/en active Active
- 2008-01-22 JP JP2009546451A patent/JP5579445B2/ja active Active
- 2008-01-22 AU AU2008209473A patent/AU2008209473B2/en active Active
- 2008-01-22 ES ES08724721.9T patent/ES2542509T3/es active Active
- 2008-01-22 DK DK08724721.9T patent/DK2117578T3/en active
- 2008-01-22 CA CA2674384A patent/CA2674384C/en active Active
- 2008-01-22 US US12/018,080 patent/US7888462B2/en active Active
-
2010
- 2010-12-15 US US12/968,532 patent/US8426558B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2117578A4 (en) | 2012-03-28 |
| US20110105401A1 (en) | 2011-05-05 |
| EP2117578B1 (en) | 2015-04-22 |
| CA2674384A1 (en) | 2008-07-31 |
| DK2117578T3 (en) | 2015-07-20 |
| JP2010516685A (ja) | 2010-05-20 |
| WO2008091632A3 (en) | 2008-12-31 |
| US7888462B2 (en) | 2011-02-15 |
| AU2008209473B2 (en) | 2012-10-25 |
| ES2542509T3 (es) | 2015-08-06 |
| CA2674384C (en) | 2016-11-15 |
| EP2117578A2 (en) | 2009-11-18 |
| US20090074876A1 (en) | 2009-03-19 |
| JP5579445B2 (ja) | 2014-08-27 |
| AU2008209473A1 (en) | 2008-07-31 |
| WO2008091632A2 (en) | 2008-07-31 |
| US8426558B2 (en) | 2013-04-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2009007693A (es) | Composicion de peptido y metodo para promover la formacion de cartilago. | |
| ATE538816T1 (de) | Verfahren zur herstellung eines bioaktiven implantats | |
| MY152282A (en) | Compositions and methods for use antibodies against sclerostin | |
| ATE518496T1 (de) | Verfahren zur gewinnung von lebensfähigen kleinen gewebeteilchen und ihre verwendung für die gewebereparatur | |
| EA201691260A1 (ru) | ВАРИАНТЫ, ПРОИСХОДЯЩИЕ ИЗ ActRIIB, И ИХ ПРИМЕНЕНИЕ | |
| WO2011088157A3 (en) | Particle/polyurethane composites and methods thereof | |
| MX368173B (es) | Una composición farmacéutica que comprende una proteína de fusión actriia-fc expresada de células cho. | |
| MEP59208A (en) | Activin-actriia antagonists and uses for promoting bone growth | |
| WO2009142770A3 (en) | Compositions and methods for generating musculoskeletal tissue | |
| MX2009010049A (es) | Metodos y composiciones para promover la salud de huesos y articulaciones. | |
| EP1755643A4 (en) | Compositions and methods for the stimulation or enhancement of bone formation and the self-renewal of cells | |
| PL2029184T3 (pl) | Wstrzykiwalna kompozycja do augmentacji kości | |
| DE602007011920D1 (de) | Injizierbarer füllstoff für knochenhohlräume | |
| WO2008046405A3 (de) | Behandlung von osteoporose | |
| ZA201007099B (en) | Method for enhanced production of bone morphogenetic proteins | |
| WO2008058233A3 (en) | In vivo bioreactors and methods of making and using same | |
| WO2009034452A3 (en) | Compound and device for treating bone and/or cartilage defects | |
| EP2340039A4 (en) | USE OF IL-20 ANTAGONISTS FOR TREATING RHEUMATOID ARTHRITIS AND OSTEOPOROSIS | |
| EP2182888A4 (en) | METHODS AND COMPOSITIONS FOR THE ADMINISTRATION OF GROWTH FACTOR TO A FIBROUS CONJUNCTIVE TISSUE | |
| IN2014KN01026A (es) | ||
| WO2011093647A3 (en) | Genes implicated in osteoarthritis and use thereof | |
| RU2009138989A (ru) | Способ лечения оскольчатых переломов трубчатых костей | |
| RU2010105813A (ru) | Способ лечения переломов пяточной кости | |
| BRPI0822542A2 (pt) | "método de preparação de uma composição de gel de colágeno para regeneração óssea" | |
| RU2007115335A (ru) | Способ костной пластики больших дефектов большеберцовой кости |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |